Marsh & McLennan Companies
MRSH · NYSE
About MRSH
- Employees
- 95,000
- Headquarters
- New York City, New York
- Listed
- Jun 4, 1969
- Sector
- Financials
- Industry
- Insurance
- Website
- marshmclennan.com
MRSH key statistics
- Market cap
- 90.95B
- Price-earnings ratio
- 22.55
- Dividend yield
- 1.98%
- Average volume
- 2.87M
- Volume
- 2.14M
- Open price
- $190.58
- High today
- $193.06
- Low today
- $189.23
- 52 Week high
- $198.49
- 52 Week low
- $156.60
Marsh & McLennan Companies (MRSH) at a glance
As of Oct 20, 2026, Marsh & McLennan Companies (MRSH) shares are priced at $191.26, giving the company a market cap of 90.95B, a price-to-earnings ratio of 22.55 and a dividend yield of 1.98%.
Today the stock has traded between $189.23 and $193.06. The current price is 1.1% above the day's low and 0.9% below its high.
Volume so far is 2.14M shares, below the average of 2.87M shares a day.
Over the past year Marsh & McLennan Companies has ranged from $156.60 to $198.49, and now sits 83% of the way up that range.
Marsh & McLennan Companies met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q3 FY26 it reported $2.03 per share against an estimate of $2.01.
The average analyst price target is $208.82, 9.2% above the current price, from 14 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy42.9%
- Hold50.0%
- Sell7.1%
- Low
- $183.82
- Now
- $191.26
- High
- $245.70
MRSH earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 2.1% on average.
- Q4 FY24: reported $1.87 per share against an estimate of $1.79
- Q1 FY25: reported $3.06 per share against an estimate of $3.08
- Q2 FY25: reported $2.72 per share against an estimate of $2.71
- Q3 FY25: reported $1.85 per share against an estimate of $1.82
- Q4 FY25: reported $2.12 per share against an estimate of $2.01
- Q1 FY26: reported $3.29 per share against an estimate of $3.29
- Q2 FY26: reported $2.96 per share against an estimate of $2.96
- Q3 FY26: reported $2.03 per share against an estimate of $2.01
MRSH news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Aging Populations Are Straining Retirement Systems Worldwide, According to the 2026 Marsh CFA Institute Global Pension Index
- Press releaseBusiness Wire
Rapid AI Capability Development Is Creating Opportunities for Those Companies With Leadership That Translate Productivity Gains Into Business Value
- Press releaseBusiness Wire
Marsh Reports Third Quarter 2026 Results
- Press releaseBusiness Wire
Marsh and Bloomberg New Economy Launch Coalition to Strengthen Resilience and Drive Growth in a Turbulent World
- Press releaseBusiness Wire
Marsh Completes Acquisition of Accel Holdings
- Press releaseBusiness Wire
Archer by Marsh Launches to Help Life and Annuity Insurers and Asset Managers Build and Operate Reinsurance Businesses
- Press releaseBusiness Wire
Marsh Appoints Birgit Boykin Chief People Officer of Oliver Wyman and Marsh Management Consulting
Similar companies
Companies in the same industry as Marsh & McLennan Companies
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.